全部 标题 作者
关键词 摘要


Breast Cancer in Men: Characteristics Epidemiological, Clinicopathological and Therapeutic

DOI: 10.4236/oalib.1103166, PP. 1-4

Subject Areas: Oncology

Keywords: Breast Cancer, Men, Epidemiology, Clinical, Therapeutic

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: Breast cancer is the leading malignancy in women, but it is relatively rare in men, accounting for 1% of all breast cancers. In Morocco, its incidence is 0.8/ 100,000 in men. This condition epidemiology, therapeutic and prognostic remains unknown given the scarcity of reported series. The objective of this work is to identify the epidemiological, clinical, pathological and therapeutic of this cancer in men. Results: Six patients were diagnosed with breast cancer with a ratio of 6/1277 cases. The mean age of patients was 63.3 ± 9.7 ans; the most common histological type was invasive ductal carcinoma (83.3%). The grade 2 SBR has a majority (66.7%), while that of SBR 3 is less represented (33.3%). A positive estrogen receptor (66.7% of cases) and progesterone (50.0% of cases) was noted. The HER2 receptor is overexpressed in 25% of cases. The treatment was essentially surgical (83.3%). Additional treatment included adjuvant chemotherapy (50.0%), radiotherapy (50.0%) and hormonal therapy (16.7%) was administered. Discussion/Conclusion: Breast cancer in men is rare and appears to have a very close clinical, histological characteristics and prognosis to those of elderly women. The diagnosis is usually late and tumors are treated in advanced stages. An improved prognosis requires better awareness for early detection.

Cite this paper

Khalil, A. I. , Mestaghanmi, H. , Qachach, F. , Saile, R. , Bendahhou, K. and Benider, A. (2016). Breast Cancer in Men: Characteristics Epidemiological, Clinicopathological and Therapeutic. Open Access Library Journal, 3, e3166. doi: http://dx.doi.org/10.4236/oalib.1103166.

References

[1]  Comet, B., Cutuli, B., Penault-Llorca, F., Bonneterre, J. and Belkacemi, Y. (2009) Male Breast Cancer: A Review. Bulletin Cancer, 96, 181-189.
[2]  Giordano, S.H., Cohen, D.S., Buzdar, A.U., Perkins, G. and Hortobagyi, G.N. (2004) Breast Carcinoma in Men: A Population Based Study. Cancer, 101, 51-57.
http://dx.doi.org/10.1002/cncr.20312
[3]  Weiss, J.R., Moysich, K.B. and Swede, H. (2005) Epidemiology of Male Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention, 14, 20-26.
[4]  Registre des cancers de la Region de Grand Casablanca (2005, 2006, 2007) édition 2012.
[5]  Benchellal, Z., Wagner, A., Harchaoui, Y., Huten, N. and Body G. (2002) Cancer du sein chez l’homme : A propos de 19 cas. Annales de Chirurgie, 127, 619-623.
http://dx.doi.org/10.1016/S0003-3944(02)00816-7
[6]  Donegan, W.L., Redlich, P.N., Lang, P.J. and Gall, M.T. (1998) Carcinoma of the Breast in Males: A Multiinstitutional Survey. Cancer, 83, 498-509.
http://dx.doi.org/10.1002/(SICI)1097-0142(19980801)83:3<498::
AID-CNCR19>3.0.CO;2-R

[7]  Goss, P.E., Reid, C., Pintilie, M., Lim, R. and Miller, N. (1999) Male Breast Carcinoma: A Review of 229 Patients Who Presented to the Princess Margaret Hospital during 40 Years: (1955-1996). Cancer, 85, 629-639.
http://dx.doi.org/10.1002/(SICI)1097-0142(19990201)85:3<629::
AID-CNCR13>3.0.CO;2-V

[8]  Wilsher, P.C., Leach, I.H. and Ellis, I.O. (1997) A Comparison Outcome of Male Breast Cancer with Female Breast Cancer. The American Journal of Surgery, 173, 185-188.
http://dx.doi.org/10.1016/S0002-9610(97)89592-X
[9]  Memon, M.A., and Donohue, J.H. (1997) Male Breast Cancer. British Journal of Surgery, 84, 433-435.
http://dx.doi.org/10.1002/bjs.1800840402
[10]  Jaiyesimi, A., Buzdar, A.U., Sahin, A.A. and Ross, M.A. (1992) Carcinoma of the Male Breast. Annals of Internal Medicine, 117, 771-777.
http://dx.doi.org/10.7326/0003-4819-117-9-771
[11]  Harlan, L.C., Zujewski, J.A., Goodman, M.T., Goodman, M.T. and Stevens, J.L. (2010 Breast Cancer in Men in the United States: A Population-Based Study of Diagnosis, Treatment, and Survival. Cancer, 116, 3558-3568.
http://dx.doi.org/10.1002/cncr.25153
[12]  Ndom, P., Um, G., Bell, E.M., Eloundou, A., Houssain, N.M. and Huo, D. (2012) Ameta- Analysis of Male Breast Cancer in Africa. Breast, 21, 237-241.
http://dx.doi.org/10.1016/j.breast.2012.01.004
[13]  El Hajjam, M., Khaiz, D., Benider, A., Lakhloufi, A., Abi, F., Kahlain, A., et al. (1995) Cancer du sein chez l’homme. à propos de 50 observations. Journal de Chirurgie, 132, 131- 136.
[14]  Storm, H.H. and Olsen, J. (1999) Risk of Breast Cancer in Offspring of Male Breast-Cancer Patients. Lancet, 353, 209.
http://dx.doi.org/10.1016/S0140-6736(05)77219-6
[15]  Fentiman, I.S., Fourquet, A. and Hortobagyi, G.N. (2006) Male Breast Cancer. Lancet, 367 595-604.
http://dx.doi.org/10.1016/S0140-6736(06)68226-3
[16]  Korde, L.A., Zujewski, J.A., Kamin, L., Giodano, S., Domchek, S. anderson, W.F., Bartlet, J.M., Gelmon, K., Nahleh, Z., Bergh, J., Cutuli, B., Pruneri, G., McCaskil-Stevens, W., Gralow, J., Hortobagyi, G. and Cardoso, F. (2010) Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations. Journal of Clinical Oncology, 28, 2114-2122.
http://dx.doi.org/10.1200/JCO.2009.25.5729
[17]  Bezwoda, W.R., Hesdorffer, C., Dansey, R., De Moor, N., Derman, D.P. and Browde, S. (1987) Breast Cancer in Men. Clinical Features, Hormone Receptor Status, and Response to Therapy. Cancer, 60, 1337-1340.
http://dx.doi.org/10.1002/1097-0142(19870915)60:6<1337::AID-
CNCR2820600629>3.0.CO;2-C

[18]  Cutuli, B.F., Lacroze, M., Dilhuydy, J.M., Florentz, P., Velten, M., Allavena, C., De Lafontan, B., Resbeut, M., Campana, F., Graic, Y., et al. (1992) Breast Cancer in Men: Incidence and Types of Associated Previous Synchronous and Metachronous Cancers. Bull Cancer, 79, 689-696.
[19]  Lenfant-Pejovic, M.H., Mlika-Cabanne, N., Bouchardy, C. and Auquier, A. (1990) Risk Factors for Male Breast Cancer: A Franco-Swiss Case-Control Study. International Journal of Cancer, 45, 661-665.
http://dx.doi.org/10.1002/ijc.2910450415
[20]  Casagrande, J.T., Hanisch, R., Pike, M.C., Ross, R.K., Brown, J.B. and Henderson B.E. (1988) A Case-Control Study of Male Breast Cancer. Cancer Research, 48, 1326-1330.
[21]  Satram-Hoang, S., Ziogas, A. and Anton-Culver, H. (2007) Risk of Second Primary Cancer in Men with Breast Cancer. Breast Cancer Research, 9, R10.
http://dx.doi.org/10.1186/bcr1643
[22]  Hines, S.L., Tan, W.W., Yasrebi, M., DePeri, E.R. and Perez, E.A. (2007) The Role of Mammography in Male Patients with Breast Symptoms. Mayo Clinic Proceedings, 82, 297- 300.
http://dx.doi.org/10.1016/S0025-6196(11)61025-2
[23]  Giordano, S.H., Valero, V., Buzdar, A.U. and Hortobagyi, G.N. (2002) Efficacy of Anastrozole in Male Breast Cancer. American Journal of Clinical Oncology, 25, 235-237.
http://dx.doi.org/10.1097/00000421-200206000-00006
[24]  Oger, A.-S., Boukerrou, M., Cutuli, B., Campion, L., Rousseau, E., Bussières, E., Raro, P. and Classe, J.-M. (2015) Le cancer du sein chez l’homme: approche épidémiologique, diagnostique, et thérapeutique: étude multicentrique rétrospective à propos de 95 cas. Gynécologie Obstétrique & Fertilité, 43, 290-296.
http://dx.doi.org/10.1016/j.gyobfe.2015.02.010
[25]  Cloyd, J.M., Hernandez-Boussard, T. and Wapnir, I.L. (2013) Outcomes of Partial Mastect- omy in Male Breast Cancer Patients: Analysus of SEER, 1983-2009. Annals of Surgical Oncology, 20, 1545-1550.
http://dx.doi.org/10.1245/s10434-013-2918-5
[26]  Giordano, S.H., Buzdar, A.U. and Hortobagyi, G.N. (2002) Breast Cancer in Men. Annals of Internal Medicine, 137, 678-687.
http://dx.doi.org/10.7326/0003-4819-137-8-200210150-00013
[27]  Hill, A., Yagmur, Y., Tran, K.N., Bolton, J.S., Robson, M. and Borgen, P.I. (1999) Localized Male Breast Carcinoma and Family History. Cancer, 86, 821-825.
http://dx.doi.org/10.1002/(SICI)1097-0142(19990901)86:5
<821::AID-CNCR18>3.0.CO;2-I

[28]  Cutuli, B., Lacroze, M., Dilhuydy, J.M., Velten, M., De Lafontan, B., Marchal, C., et al. (1995) Male Breast Cancer: Results of the Treatments and Prognostic Factors in 397 Cases. European Journal of Cancer, 31A, 1960-1964.
http://dx.doi.org/10.1016/0959-8049(95)00366-5
[29]  Tunon de Lara, C., Goudy, G., MacGrogan, G., Durand, M., Dilhuydy, J.-M., Avril, A., Stoeckle, E., Bussieres, J.-E., Debled, M., de Mascarel, I. and Mauriac, L. (2008) Male Breast Cancer: A Review of 52 Cases Collected at the Institute Bergonie’ (Bordeaux, France) from 1980 to 2004. Gynécologie Obstétrique & Fertilité, 36, 386-394.
http://dx.doi.org/10.1016/j.gyobfe.2008.02.020
[30]  Sachs, M.D. (1941) Carcinoma of the Male Breast. Radiology, 37, 458-467.
http://dx.doi.org/10.1148/37.4.458
[31]  Stalsberg, H., Thomas, D.B., Rosenblatt, K.A., Jimenez, L.M., McTiernan, A., Stemhagen, A., et al. (1993) Histologic Types and Hormone Receptors in Breast Cancer in Men: A Population-Based Study in 282 United States Men. Cancer Causes Control, 4, 143-151.
http://dx.doi.org/10.1007/BF00053155
[32]  Ribeiro, G. and Swindell, R. (1992) Adjuvant Tamoxifen for Male Breast Cancer (MBC). British Journal of Cancer, 65, 252-254.
http://dx.doi.org/10.1038/bjc.1992.50

Full-Text


comments powered by Disqus